Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Pawłowski, G. Nowak, Z. Górka, H. Mazela (2004)
Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: Effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activitiesPsychopharmacology, 86
H. Westenberg, J. Boer (1993)
Serotonin in Anxiety and Related Disorders
Giesecke Me (1990)
Overcoming hypersensitivity to fluoxetine in a patient with panic disorder.American Journal of Psychiatry, 147
M. Linnoila, M. Eckardt, M. Durcan, R. Lister, P. Martin (1987)
Interactions of serotonin with ethanol: clinical and animal studies.Psychopharmacology bulletin, 23 3
H. Westenberg, J. Boer (1988)
Clinical and Biochemical Effects of Selective Serotonin-Uptake Inhibitors in Anxiety Disorders, 17
R. Invernizzi, S. Belli, R. Samanin (1992)
Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortexBrain Research, 584
D. Fontana, T. Carbary, R. Commissaris (2004)
Effects of acute and chronic anti-panic drug administration on conflict behavior in the ratPsychopharmacology, 98
B. Saletu, J. Grünberger (1985)
Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses.The Journal of clinical psychiatry, 46 3 Pt 2
G. Griebel, R. Misslin, M. Pawlowski, B. Lemaître, G. Guillaumet, J. Bizot-Espiard (1992)
Anxiolytic-like effects of a selective 5-HT1A agonist, S20244, and its enantiomers in mice.Neuroreport, 3 1
S. Bodnoff, B. Suranyi-Cadotte, D. Aitken, R. Quirion, M. Meaney (2004)
The effects of chronic antidepressant treatment in an animal model of anxietyPsychopharmacology, 95
M. Åsberg, B. Eriksson, B. Mårtensson, L. Träskman-bendz, A. Wägner (1986)
Therapeutic effects of serotonin uptake inhibitors in depression.The Journal of clinical psychiatry, 47 Suppl
L. Pawłowski, H. Kwiatek, Z. Górka (2005)
Is Ro 11-2465 (Cyan-imipramine) an antagonist of postsynaptic serotonin receptors?Journal of Neural Transmission, 52
G. Griebel, M. Saffroy-Spittler, R. Misslin, E. Vogel, James Martin (2005)
Serenics fluprazine (DU 27716) and eltoprazine (DU 28853) enhance neophobic and emotional behaviour in micePsychopharmacology, 102
J. Maj, E. Moryl (2005)
Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulationsJournal of Neural Transmission / General Section JNT, 88
L. Maître, P. Moser, P. Baumann, P. Waldmeier (1980)
AMINE UPTAKE INHIBITORS: CRITERIA OF SELECTIVITYActa Psychiatrica Scandinavica, 61
J. Hyttel (1977)
Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171Psychopharmacology, 51
S. Pellow (1986)
Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid?Methods and findings in experimental and clinical pharmacology, 8 9
G. Griebel, R. Misslin, M. Pawlowski, E. Vogel (1991)
m-Chlorophenylpiperazine enhances neophobic and anxious behaviour in mice.Neuroreport, 2 10
S. File, A. Bond, R. Lister (1982)
Interaction Between Effects of Caffeine and Lorazepam in Performance Tests and Self‐RatingsJournal of Clinical Psychopharmacology, 2
C. Belzung, R. Misslin, E. Vogel, R. Dodd, G. Chapouthier (1987)
Anxiogenic effects of methyl-β-carboline-3-carboxylate in a light/dark choice situationPharmacology Biochemistry and Behavior, 28
S. File (1985)
Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour.Neuropsychobiology, 13 1-2
S. Montgomery (1991)
Clinical significance of 5‐HT uptake inhibitorsHuman Psychopharmacology: Clinical and Experimental, 6
J. Gorman, M. Liebowitz, A. Fyer, Deborah Goetz, R. Campeas, M. Fyer, S. Davies, D. Klein (1987)
An Open Trial of Fluoxetine in the Treatment of Panic AttacksJournal of Clinical Psychopharmacology, 7
S. Pellow, S. File (1986)
Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the ratPharmacology Biochemistry and Behavior, 24
M. Prada, H. Keller, W. Burkard, R. Schaffner, E. Bonetti, J. Launay, W. Haefely (1982)
Some neuropharmacological effects of Ro 11-2465--a novel tricyclic antidepressant with potent inhibitory activity on the uptake of 5-HT.Advances in biochemical psychopharmacology, 31
S. Pellow, A. Johnston, S. File (1987)
Selective agonists and antagonists for 5‐hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus‐maze test in the ratJournal of Pharmacy and Pharmacology, 39
H. Praag (1988)
Serotonin Disturbances in Psychiatric Disorders: Functional versus Nosological Interpretation, 17
Y. Chaput, C. Montigny, P. Blier (1991)
Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 5 4
A. Adell, F. Artigas (1991)
Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortexNaunyn-Schmiedeberg's Archives of Pharmacology, 343
L. Maître, P. Baumann, J. Jackel, P. Waldmeier (1982)
5-HT uptake inhibitors: psychopharmacological and neurobiochemical criteria of selectivity.Advances in biochemical psychopharmacology, 34
T. Insel, E. Mueller, I. Alterman, M. Linnoila, D. Murphy (1985)
Obsessive-compulsive disorder and serotonin: Is there a connection?Biological Psychiatry, 20
L. Rägo, R. Kiivet, J. Harro, M. Põld (1988)
Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortexNaunyn-Schmiedeberg's Archives of Pharmacology, 337
S. Bodnoff, B. Suranyi-Cadotte, R. Quirion, M. Meaney (2004)
A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxietyPsychopharmacology, 97
213 113 113 3 4 Guy Griebel Jean-Luc Moreau François Jenck René Misslin James R. Martin Laboratoire de Psychophysiologie 7 rue de l'Université F-67000 Strasbourg France Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd CH-4002 Basel Switzerland Abstract This study investigated behavioural effects of very potent 5-HT reuptake inhibitors after acute treatment (cianopramine and citalopram), as well as after chronic treatment (cianopramine), in two behavioural models of anxiety: 1) the light/dark choice procedure in mice and 2) the elevated plus-maze test in rats. In addition, the responses of mice to novelty in a free exploration paradigm were assessed after acute administration of both drugs. A single injection of cianopramine or citalopram increased neophobic reactions in the free exploration test. Furthermore, these drugs increased the avoidance reaction to a brightly illuminated chamber in the light/dark choice procedure as well as to open arms in the elevated plus-maze test. In contrast, after chronic treatment (10 mg/kg IP, once daily for 21 days) of cianopramine, anxiogenic-like effects were no longer produced in the light/dark choice paradigm whereas in the elevated plus-maze test, anxiolytic-like effects appeared. These results shed more light on the 5-HT hypothesis of anxiety, insofar as the increased availability of 5-HT resulting here from reuptake inhibition seems to initially result in an increased emotional reactivity which, however, subsequently disappears during chronic treatment.
Psychopharmacology – Springer Journals
Published: Jan 1, 1994
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.